The stock of Biocon saw a sharp rally in May, gaining nearly 20 per cent. But in June, it was largely sideways and even ...

Read all the latest news headline updates on biocon stock. Get all the biocon stock breaking news updates, videos, photostories and more at Business Standard.

Profit rises 71% YoY to Rs 144 crore Biocon Biologics share which constitutes 45% of revenues reported 29% YoY growth to Rs ...

The stock that we have today is Biocon. After a sharp rally in May, the stock lost some momentum and was largely sideways in ...

Tech Mahindra, Axis Bank, Godrej Properties, RITES, SIS, Jagsonpal Pharma, and Sterling and Wilson Renewable Energy are top ...

Solid earnings, robust biosimilars growth, and improving margins drive renewed optimism; analysts see double-digit upside ...

Top picks include for Monday, July 6 include Biocon, IndusInd Bank, Lupin, Angel One, and Electronics Mart India.

Biocon's Malaysian partner Duopharma Biotech secures insulin supply contracts worth over MYR 225 million from Malaysia's ...

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced that Siddharth Mittal has assumed the role of Managing Director and Chief ...

Biocon Biologics and Regeneron executed the settlement agreement to dismiss the pending appeal at the United States Court of Appeals for the Federal Circuit (USCAFC) of patent US11084865 ('865 patent) ...

Viatris Inc. , the company formed by the merger of Mylan and Pfizer Inc. unit Upjohn in 2020, said Monday it has reached an agreement to combine its biosimilars portfolio with Biocon Biologics Ltd.

Indian contract research, development and manufacturing organization Syngene International has appointed Siddharth Mittal as managing director and chief executive.